BeOne Medicines Ltd. – Credit Agreements

EX-10.3

from 10-Q 15 pages Certain Confidential Portions of This Exhibit Were Omitted and Replaced With “[...***...].” a Complete Version of This Exhibit Has Been Filed Separately With the Secretary of the U.S. Securities and Exchange Commission Pursuant to an Application Requesting Confidential Treatment Pursuant to Rule 24b-2 Under the Securities Exchange Act of 1934, as Amended. Shareholder Loan Contract With Respect to BeiGene Biologics Co., Ltd Between Guangzhou Get Technology Development Co., Ltd. and BeiGene Biologics Co., Ltd Date: March 7, 2017

12/34/56

EX-10.4

from 10-Q 3 pages Certain Confidential Portions of This Exhibit Were Omitted and Replaced With “[...***...].” a Complete Version of This Exhibit Has Been Filed Separately With the Secretary of the U.S. Securities and Exchange Commission Pursuant to an Application Requesting Confidential Treatment Pursuant to Rule 24b-2 Under the Securities Exchange Act of 1934, as Amended. Supplemental Agreement to the Entrusted Loan Contract

12/34/56

EX-10.13

from S-1 21 pages Certain Confidential Portions of This Exhibit Were Omitted and Replaced With “[...***...].” a Complete Version of This Exhibit Has Been Filed Separately With the Secretary of the Securities and Exchange Commission Pursuant to an Application Requesting Confidential Treatment Pursuant to Rule 406 Under the Securities Act of 1933, as Amended. Entrusted Loan Contract

12/34/56

BeOne Medicines Ltd. – Credit Agreements

Search in Documents

Key Exhibits

External Links

Credit Agreements Filter

BeOne Medicines Ltd. – Credit Agreements Watch

Search in Documents

Key Exhibits

External Links

Credit Agreements Filter

BeOne Medicines Ltd. – Credit Agreements